Neogenomics (NEO) Convertible Debt (2020 - 2026)

Neogenomics (NEO) has reported Convertible Debt for 7 consecutive years, with $342.2 million the latest figure, recorded in Q1 2026.

• Convertible Debt for Q1 2026 came in at $342.2 million, changed 0.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $342.2 million (changed 0.45% YoY), and the FY2025 annual result was $341.9 million, changed 0.45% from the prior year.
• Convertible Debt was $342.2 million for Q1 2026 at Neogenomics, roughly flat from $341.9 million in the prior quarter.
• Over five years, Convertible Debt peaked at $538.9 million in Q1 2024 and troughed at $339.6 million in Q2 2024.
• Average Convertible Debt over 5 years is $444.2 million, with a median of $533.2 million recorded in 2022.
• Year-over-year, Convertible Debt grew 0.54% in 2024 and slumped 36.78% in 2025.
• Over 5 years, Convertible Debt stood at $535.3 million in 2022, then gained by 0.54% to $538.2 million in 2023, then plunged by 36.76% to $340.3 million in 2024, then grew by 0.45% to $341.9 million in 2025, then advanced by 0.11% to $342.2 million in 2026.
• Per Business Quant data, the three most recent Convertible Debt figures were $342.2 million in Q1 2026, $341.9 million in Q4 2025, and $341.5 million in Q3 2025.